Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial
暂无分享,去创建一个
E. Ashley | L. Pinoges | Y. Boum | P. Houzé | P. Guérin | B. Schramm | M. Dhorda | Richard Smith | V. Jullien | E. Baudin | E. Comte | G. Carn | J. Kiechel | Joel J. Jones | Yah M. Zolia | P. Valeh | C. Mazinda | Timothy Sundaygar | É. Comte
[1] E. Ashley,et al. Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia , 2013, Malaria Journal.
[2] F. Nosten,et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.
[3] P. Guérin,et al. Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial , 2012, Malaria Journal.
[4] A. Dash,et al. Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India , 2012, Malaria Journal.
[5] Renuka Kunte,et al. WHO Guidelines for the treatment of malaria , 2011 .
[6] B. Cissé,et al. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial , 2011, Malaria Journal.
[7] A. Rasheed,et al. Efficacy and safety of artemehter-lumefantrine in uncomplicated falciparum malaria in Liberia. , 2011, JPMA. The Journal of the Pakistan Medical Association.
[8] Lorenz von Seidlein,et al. Artemisinin resistance: current status and scenarios for containment , 2010, Nature Reviews Microbiology.
[9] J. Ndiaye,et al. Efficacy and tolerability of artesunate‐amodiaquine (Camoquin plus®) versus artemether‐lumefantrine (Coartem®) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast , 2010, Tropical medicine & international health : TM & IH.
[10] R. Price,et al. In vivo parasitological measures of artemisinin susceptibility. , 2010, The Journal of infectious diseases.
[11] Icf Macro. Liberia Malaria Indicator Survey 2009 , 2009 .
[12] J. Ndiaye,et al. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis , 2009, Malaria Journal.
[13] Paul Garner,et al. Artemisinin-based combination therapy for treating uncomplicated malaria. , 2009, The Cochrane database of systematic reviews.
[14] P. Houzé,et al. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. , 2009, The Journal of infectious diseases.
[15] J. Ndiaye,et al. Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria , 2009, Malaria Journal.
[16] J. Keiser,et al. A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[17] L. Gustafsson,et al. Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combination , 2009, Malaria Journal.
[18] S. Sirima,et al. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum , 2009, Malaria Journal.
[19] M. Fukuda,et al. Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.
[20] R. Price,et al. Simplified antimalarial therapeutic monitoring: using the day-7 drug level? , 2008, Trends in parasitology.
[21] F. Nosten,et al. Artemisinin-based combination treatment of falciparum malaria. , 2007, The American journal of tropical medicine and hygiene.
[22] D. Blessborn,et al. Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. , 2007, Journal of pharmaceutical and biomedical analysis.
[23] C. Whitty,et al. Artemisinin-based combination treatment for malaria in Africa: no perfect solutions. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Abdullah S. Ali,et al. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] F. Checchi,et al. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[26] F. Checchi,et al. Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[27] C. Karema,et al. A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial , 2011 .
[28] Organización Mundial de la Salud. Guidelines for the treatment of malaria , 2010 .
[29] Organización Mundial de la Salud. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations , 2008 .